Natural history of Waldenstrom macroglobulinemia following acquired resistance to ibrutinib monotherapy

Gustine, JN; Sarosiek, S; Flynn, CA; Meid, K; Leventoff, C; White, T; Guerrera, ML; Xu, L; Kofides, A; Tsakmaklis, N; Munshi, M; Demos, M; Patterson, CJ; Liu, X; Yang, G; Hunter, ZR; Branagan, AR; Treon, SP; Castillo, JJ

Castillo, JJ (通讯作者)，Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, Boston, MA 02115 USA.;Castillo, JJ (通讯作者)，Harvard Med Sch, Dept Med, Boston, MA 02115 USA.

HAEMATOLOGICA, 2022; 107 (5): 1163

Abstract

Ibrutinib is highly active and produces long-term responses in patients with Waldenstrom macroglobulinemia (WM), but acquired resistance can occur wit......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索